<DOC>
	<DOCNO>NCT02287285</DOCNO>
	<brief_summary>Longitudinal study beta cell function 2 year GBP surgery . Evaluation role endogenous glucagon-like peptide-1 ( GLP-1 ) .</brief_summary>
	<brief_title>Determinants Diabetes Remission After Gastric Bypass Surgery</brief_title>
	<detailed_description>The increase prevalence obesity type 2 diabetes ( T2DM ) result surge number patient seek surgical weight loss . Gastric bypass surgery ( GBP ) result 30-40 % body weight loss resolution T2DM 40-80 % case . The mechanisms T2DM improve GBP unclear . Glycemic control occur long significant weight loss , suggest nature procedure , rather weight loss , responsible T2DM improvement . Recent data single role gut hormone know incretins diabetes improvement GBP . The current proposal study 1 ) whether short long term change gut hormone incretins GBP result improve insulin secretion response administration oral IV glucose , patient diabetes undergoing GBP surgery ; 2 ) factor responsible diabetes remission - lack - GBP . The investigator wish apply find define well surgical outcome diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients wide range T2DM ( duration , treatment modality control , remission ) schedule GBP surgery Blood pressure least moderate control &lt; 160/100 mmHg Patients dyslipidemia medication need fast triglyceride &lt; 600 mg/dl Patients without recent ( last 6 month ) history cardiovascular disease ( CVD ) BMI &gt; 35 &lt; 55 kg/m2 prior GBP surgery Active cancer Unstable angina Recent stroke Current therapy may affect glucose metabolism glucocorticoid , HIV medication , etc Active infection Kidney failure Severe liver dysfunction Severe respiratory cardiac failure History allergic reaction exendin 939 History pancreatitis , history cholelithiasis , history alcoholism Presence high triglyceride level ( &gt; 600 ng/dl ) Pregnancy ( pregnancy test do prior enrollment prior procedure premenopausal woman )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Gastric Bypass Surgery</keyword>
	<keyword>Exendin9</keyword>
</DOC>